dr. robert carruthers, a neurologist in the
ms clinic at the university of b.c. centre for brain health, said that the recommendation from the society is sensible. while the recommendation is that individuals with ms — or at risk of ms — consume between 600 and 4,000 iu daily, carruthers said he advises his patients to take up to 5,000 iu of vitamin d3 per day. (
international units, or iu, is a measurement of the potency, or biological activity of a product.)“it’s cheap, safe, and has been shown to be helpful.”carruthers estimates that less than 10 per cent of patients coming to the ubc clinic for a new diagnosis are taking vitamin d supplements at the time of their first appointments. that suggests that a blanket recommendation like the one issued wednesday is important, to get the message out more broadly.“i encourage patients to take anywhere between 2,000 and 5,000 iu per day. we have to acknowledge we don’t exactly know the right dose but in some studies, doses as high as 10,000 units were used without any clear concerns about toxicity,” carruthers said in an interview, adding that he also advises patients to quit smoking because it can worsen the course of the disease.“with patients who have early or mild ms, you want those people to do everything possible to maintain that status, through modifiable risk reductions, including vitamin d3 supplementation and not smoking.”two ongoing trials will hopefully yield more definitive answers about the role of vitamin d as a treatment for ms. the efficacy of vitamin d supplementation in ms (
evidims) trial is a pilot study looking at the effects of high-dose vitamin d3 supplementation on brain lesions, inflammatory activity, disability progression and quality of life. another study, the vitamin d to ameliorate ms (
vidams) trial, is examining the effectiveness of high-dose vitamin d3 in reducing the relapse rate and disease activity in the brain.a recent
study done at ubc by dr. helen tremlett and her team showed that there may be some subtle signs of ms in the five years before people develop the first typically recognized symptoms.tremlett found patients eventually diagnosed with ms patients were up to four times more likely to be treated for pain or sleep problems, and 50 per cent more likely to visit a psychiatrist.the researchers found that fibromyalgia was fairly common in people who were later diagnosed with ms, as was irritable bowel syndrome. two other conditions with higher rates among those eventually diagnosed with ms were migraine headaches and any mood or anxiety disorder, including depression, anxiety and bipolar disorder.the study was the biggest to document symptoms before individuals knew they had ms. it is useful for physicians so they can diagnose the disease earlier when disease-modifying drugs could potentially slow down the damage ms can cause to the brain and spinal cord.the disease is usually confirmed by magnetic resonance imaging (mri), tests on nerve impulses, or an examination of spinal fluid.
pfayerman@postmedia.comtwitter.com/medicinemattersrelated
click here to report a typo. is there more to this story? we’d like to hear from you about this or any other stories you think we should know about. email vantips@postmedia.com.